The global demand for Brucellosis Vaccines Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Brucellosis also is known as malta fever, undulant fever, Mediterranean fever, is an infection caused by undercooked meat of infected animals or ingestion of unpasteurized milk or close contact with their secretion. Brucellosis vaccine is meant for cattle, sheep and goats. Currently, there is no vaccine available for humans. Vaccination works by producing an immune response that increases the animal's resistance to the diseases and is important to control, manage and eliminate brucellosis.
Growing livestock production and the threat of animal-borne infectious diseases are driving the growth of the market. With continuous growth and transformation of the livestock sector offer substantial challenges associated with food security and human nutrition. Demand for livestock products is growing influenced by increasing consumption of milk, meat, and eggs. Globally, brucellosis is considered as the most common zoonotic disease, with more than 500,000 cases recorded annually. Growth of the market is backed by a vaccination programme. On the other hand, there are many regions where effective diagnosis or treatment is not available or where programmes for the detection and prevention of the infection in humans and animals are not adequately carried out. Such regions need co-ordination and collaboration between veterinary and health sectors of government to help prevent and control brucellosis.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of Brucellosis Vaccines.
The entire Brucellosis Vaccines market has been sub-categorized into product type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product Type
- S19 Vaccine
- RB51 Vaccine Strain
This section covers regional segmentation which accentuates on current and future demand for Brucellosis Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Brucellosis Vaccines Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Brucellosis Vaccines market include Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, Vetal Company. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.